Adverse events188

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 188

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Arthralgia	Musculoskeletal and connective tissue disorders	Group 1: Tamoxifen + Anastrozole Placebo	358	1,535
other	Arthralgia	Musculoskeletal and connective tissue disorders	Group 2: Anastrazole + Tamoxifen Placebo	504	1,535
other	Bone pain	Musculoskeletal and connective tissue disorders	Group 1: Tamoxifen + Anastrozole Placebo	96	1,535
other	Bone pain	Musculoskeletal and connective tissue disorders	Group 2: Anastrazole + Tamoxifen Placebo	152	1,535
other	Cataract	Eye disorders	Group 1: Tamoxifen + Anastrozole Placebo	77	1,535
other	Cataract	Eye disorders	Group 2: Anastrazole + Tamoxifen Placebo	43	1,535
other	Depression	Psychiatric disorders	Group 1: Tamoxifen + Anastrozole Placebo	112	1,535
other	Depression	Psychiatric disorders	Group 2: Anastrazole + Tamoxifen Placebo	126	1,535
other	Dyspnea	Respiratory, thoracic and mediastinal disorders	Group 1: Tamoxifen + Anastrozole Placebo	101	1,535
other	Dyspnea	Respiratory, thoracic and mediastinal disorders	Group 2: Anastrazole + Tamoxifen Placebo	95	1,535
other	Fatigue	General disorders	Group 1: Tamoxifen + Anastrozole Placebo	187	1,535
other	Fatigue	General disorders	Group 2: Anastrazole + Tamoxifen Placebo	196	1,535
other	Headache	Nervous system disorders	Group 1: Tamoxifen + Anastrozole Placebo	73	1,535
other	Headache	Nervous system disorders	Group 2: Anastrazole + Tamoxifen Placebo	86	1,535
other	Hot flashes	Vascular disorders	Group 1: Tamoxifen + Anastrozole Placebo	655	1,535
other	Hot flashes	Vascular disorders	Group 2: Anastrazole + Tamoxifen Placebo	570	1,535
other	Hyperhidrosis	Skin and subcutaneous tissue disorders	Group 1: Tamoxifen + Anastrozole Placebo	124	1,535
other	Hyperhidrosis	Skin and subcutaneous tissue disorders	Group 2: Anastrazole + Tamoxifen Placebo	99	1,535
other	Infections and infestations - Other, specify	Infections and infestations	Group 1: Tamoxifen + Anastrozole Placebo	216	1,535
other	Infections and infestations - Other, specify	Infections and infestations	Group 2: Anastrazole + Tamoxifen Placebo	207	1,535

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00053898/events

API reference For AI assistants

Adverse events188

Sources 3

Read this list from software.